EL

Emily Leproust

North America, California, United States, San Francisco

Description

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world...

Investor Profile

Emily Leproust has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (67%)
  • Switzerland (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Food And Beverage
  • Artificial Intelligence (Ai)
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emily Leproust frequently co-invest with?

Catapult Ventures
North America, California, United States, Los Altos
Co-Investments: 1
SI
North America, Washington, United States, Seattle
Co-Investments: 1
Acacia Venture Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vision Plus Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
Caltech
North America, California, United States, Pasadena
Co-Investments: 1
North South Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Kindred Capital
Europe, England, United Kingdom, London
Co-Investments: 1
MV
North America, California, United States, Manhattan Beach
Co-Investments: 1

Which angels does Emily Leproust often collaborate with?

JZ
North America, California, United States
Shared Deals: 1
JP
North America, California, United States, San Francisco
Shared Deals: 1
MS
North America, California, United States
Shared Deals: 1
JG
North America, California, United States, San Francisco
Shared Deals: 1
Dario Amodei
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Emily Leproust?

Biostate AI

Palo Alto, California, United States

Biostate AI develops generative AI that benefit all human health.

BiotechnologyHealth Care
SeedJul 8, 2024
Amount Raised: $4,000,000
Cradle

Zürich, Zurich, Switzerland

Cradle is a biotech company that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins.

Artificial Intelligence (AI)BiotechnologyProduct Research
SeedNov 17, 2022
Amount Raised: $5,698,637
Kiwi Biosciences

Somerville, Massachusetts, United States

Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS).

BiotechnologyFood and BeverageHealth Care
SeedOct 14, 2021
Amount Raised: $1,500,000